Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC BIOSCIENCE HOLDING A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark XBRLDenmarkIFRS Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 0.6% 1.5%   Bankruptcy risk   0.3% 2.2% 2.2% 2.3% 0.8% 2.5% 7.5% 7.4%   Credit score (0-100)   100 68 65 64 91 62 32 33   Credit rating   AAA BBB BBB BBB AA BBB BB BB   Credit limit (mDKK)   34.0 0.0 0.0 0.0 14.6 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 226 238 225 294 205 205 205   Gross profit   245 281 256 193 243 149 0.0 0.0   EBITDA   100 124 105 57.1 82.9 -11.0 0.0 0.0   EBIT   100 124 105 57.1 82.9 -11.0 0.0 0.0   Pre-tax profit (PTP)   79.0 111.0 79.6 37.4 74.5 -15.2 0.0 0.0   Net earnings   38.3 111.0 79.6 37.4 51.6 17.0 0.0 0.0   Pre-tax profit without non-rec. items   79.0 124 105 57.1 74.5 -15.2 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   112 0.0 0.0 0.0 76.1 78.8 0.0 0.0   Shareholders equity total   238 283 137 57.8 62.4 48.8 38.2 38.2   Interest-bearing liabilities   34.7 0.0 0.0 0.0 45.5 42.7 0.0 0.0   Balance sheet total (assets)   361 453 289 220 223 269 38.2 38.2   Net Debt   -61.2 0.0 0.0 0.0 -15.2 -39.3 -38.2 -38.2     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 226 238 225 294 205 205 205   Net sales growth   0.0% 0.0% 5.2% -5.4% 30.6% -30.1% 0.0% 0.0%   Gross profit   245 281 256 193 243 149 0.0 0.0   Gross profit growth   -45.0% 14.5% -8.9% -24.5% 26.1% -38.8% -100.0% 0.0%   Employees   160 188 219 151 168 184 0 0   Employee growth %   8.8% 17.5% 16.5% -31.1% 11.3% 9.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   361 453 289 220 223 269 38 38   Balance sheet change%   -54.9% 25.5% -36.3% -23.8% 1.3% 20.7% -85.8% 0.0%   Added value   100.3 123.6 105.1 57.1 82.9 -11.0 0.0 0.0   Added value %   0.0% 54.6% 44.2% 25.4% 28.2% -5.4% 0.0% 0.0%   Investments   -11 -150 0 0 85 2 -87 0   Net sales trend   0.0 0.0 1.0 -1.0 1.0 -1.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 -1.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 54.6% 44.2% 25.4% 28.2% -5.4% 0.0% 0.0%   EBIT %   0.0% 54.6% 44.2% 25.4% 28.2% -5.4% 0.0% 0.0%   EBIT to gross profit (%)   40.9% 44.0% 41.1% 29.6% 34.0% -7.4% 0.0% 0.0%   Net Earnings %   0.0% 49.1% 33.5% 16.6% 17.6% 8.3% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 49.1% 33.5% 16.6% 17.6% 8.3% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 54.6% 44.2% 25.4% 25.4% -7.4% 0.0% 0.0%   ROA %   17.3% 30.4% 28.3% 22.4% 37.7% -8.0% 0.0% 0.0%   ROI %   22.1% 34.1% 28.3% 22.4% 50.5% -19.5% 0.0% 0.0%   ROE %   9.2% 42.6% 37.9% 38.3% 85.9% 30.6% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   65.9% 100.0% 100.0% 100.0% 41.6% 39.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 53.6% 107.3% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 33.0% 67.3% -18.6% -18.6%   Net int. bear. debt to EBITDA, %   -61.0% 0.0% 0.0% 0.0% -18.3% 355.8% 0.0% 0.0%   Gearing %   14.6% 0.0% 0.0% 0.0% 72.8% 87.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   60.2% 0.0% 0.0% 0.0% 39.5% -10.4% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 0.0 0.0 0.0 2.6 4.6 0.0 0.0   Current Ratio   2.3 0.0 0.0 0.0 1.2 1.0 0.0 0.0   Cash and cash equivalent   96.0 0.0 0.0 0.0 60.6 81.9 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 47.7 37.8 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 47.1% 88.8% 18.6% 18.6%   Net working capital   35.8 0.0 0.0 0.0 23.0 1.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 7.8% 0.9% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 1 1 1 2 1 0 0   Added value / employee   1 1 0 0 0 -0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1 1 0 0 0 -0 0 0   EBIT / employee   1 1 0 0 0 -0 0 0   Net earnings / employee   0 1 0 0 0 0 0 0